Cargando…
Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis
Studies have suggested that metformin can potentially decrease the incidence of cancer and improve survival outcomes. However, the association between metformin use and the incidence and survival of endometrial cancer (EC) remains controversial. So, a meta-analysis was performed. An electronic searc...
Autores principales: | Tang, Yun-Liang, Zhu, Ling-Yan, Li, Yu, Yu, Jiao, Wang, Jiao, Zeng, Xiang-Xia, Hu, Kai-Xiang, Liu, Jian-Ying, Xu, Ji-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376924/ https://www.ncbi.nlm.nih.gov/pubmed/28409158 http://dx.doi.org/10.1155/2017/5905384 |
Ejemplares similares
-
Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017) -
Metformin and endometrial cancer survival: a quantitative synthesis of observational studies
por: Guo, Jianfeng, et al.
Publicado: (2017) -
Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis
por: Jiao, Yu, et al.
Publicado: (2022) -
Insulin autoimmune syndrome in a pregnant female: A rare case report
por: Zeng, Xiang Xia, et al.
Publicado: (2017) -
Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes
por: Insin, Putsarat, et al.
Publicado: (2018)